How does Metoclopramide affect gastrointestinal motility in patients with scleroderma and what are the observed benefits or limitations of its use?
Lakshya KumarExplorer
How does Metoclopramide affect gastrointestinal motility in patients with scleroderma?
Share
Metoclopramide enhances GI motility in scleroderma by increasing LES tone and promoting gastric emptying. Benefits include reduced GERD symptoms; limitations involve potential side effects like drowsiness or anxiety.